Skip to main content
Top
Published in: World Journal of Pediatrics 3/2020

01-06-2020 | Coronavirus | Editorial

Diagnosis and treatment of 2019 novel coronavirus infection in children: a pressing issue

Authors: Kun-Ling Shen, Yong-Hong Yang

Published in: World Journal of Pediatrics | Issue 3/2020

Login to get access

Excerpt

The viral pneumonia in Wuhan City, China has spread around China. The virus has been proven to be a novel coronavirus (named as “2019-nCoV”) by World Health Organization (WHO). 2019-nCoV belongs to beta-coronavirus genera. On January 30, 2020, WHO re-evaluated the potential effects of 2019-nCoV infection in global public health, and declared this epidemic as a “Public Health Emergency of International Concern (PHEIC)”. …
Literature
2.
go back to reference Li ZZ, Shen KL, Wei XM, Wang HL, Lu J, Tian H, et al. Clinical analysis of pediatric SARS cases in Beijing. Chin J Pediatr. 2003;41:574–7 (in Chinese). Li ZZ, Shen KL, Wei XM, Wang HL, Lu J, Tian H, et al. Clinical analysis of pediatric SARS cases in Beijing. Chin J Pediatr. 2003;41:574–7 (in Chinese).
3.
go back to reference Yang YH. Concern for severe acute respiratory syndrome. Chin J Pediatr. 2003;41:401–2 (in Chinese). Yang YH. Concern for severe acute respiratory syndrome. Chin J Pediatr. 2003;41:401–2 (in Chinese).
4.
go back to reference Merigan TC, Reed SE, Hall TS, Tyrrell DA. Middle East respiratory syndrome coronavirus in children. Saudi Med J. 2015;36:484–6.CrossRef Merigan TC, Reed SE, Hall TS, Tyrrell DA. Middle East respiratory syndrome coronavirus in children. Saudi Med J. 2015;36:484–6.CrossRef
5.
go back to reference Merigan TC, Reed SE, Hall TS, Tyrrell DA. Inhibition of respiratory virus infection by locally applied interferon. Lancet. 1973;17:563–7.CrossRef Merigan TC, Reed SE, Hall TS, Tyrrell DA. Inhibition of respiratory virus infection by locally applied interferon. Lancet. 1973;17:563–7.CrossRef
6.
go back to reference Chen PL, Zhang TX, Hu YH, Zhou CF, Wang SD. A multicenter randomized controlled clinical study of recombinant human interferon-typeα1b in the treatment of viral pneumonia in children. Lin Chuang Er Ke Za Zhi. 2005;23:244–5 (in Chinese). Chen PL, Zhang TX, Hu YH, Zhou CF, Wang SD. A multicenter randomized controlled clinical study of recombinant human interferon-typeα1b in the treatment of viral pneumonia in children. Lin Chuang Er Ke Za Zhi. 2005;23:244–5 (in Chinese).
7.
go back to reference Shang YX, Huang Y, Liu EM, Chen Q, Cao L, Lu M, et al. A multicenter study on the treatment of acute bronchiolitis by nebulized human recombinant human interferon-alpha 1b. Zhongguo Shi Yong Er Ke Za Zhi. 2014;29:840–4 (in Chinese). Shang YX, Huang Y, Liu EM, Chen Q, Cao L, Lu M, et al. A multicenter study on the treatment of acute bronchiolitis by nebulized human recombinant human interferon-alpha 1b. Zhongguo Shi Yong Er Ke Za Zhi. 2014;29:840–4 (in Chinese).
8.
go back to reference Xu YL, Tian QL, Jiang TY, Panf BD, Feng X, Pang L, et al. Effect of nebulized inhalation of recombinant human interferon alpha-1b on early treatment of severe hand, foot and mouth disease. Zhonghua Shi-Yong Er Ke Za Zhi. 2015;30:627–30 (in Chinese). Xu YL, Tian QL, Jiang TY, Panf BD, Feng X, Pang L, et al. Effect of nebulized inhalation of recombinant human interferon alpha-1b on early treatment of severe hand, foot and mouth disease. Zhonghua Shi-Yong Er Ke Za Zhi. 2015;30:627–30 (in Chinese).
9.
go back to reference Shen KL, Shang YX, Zhang GC, Xu BP, Fu Z, Cao L, et al. Rational use of interferon alpha in pediatrical clinical practice: experts' consensus statement. Zhonghua Shi Yong Er Ke Za Zhi. 2018;33:1301–8 (in Chinese). Shen KL, Shang YX, Zhang GC, Xu BP, Fu Z, Cao L, et al. Rational use of interferon alpha in pediatrical clinical practice: experts' consensus statement. Zhonghua Shi Yong Er Ke Za Zhi. 2018;33:1301–8 (in Chinese).
10.
go back to reference Shen KL, Shang YX, Zhang H. A multicenter, randomized, controlled clinical study on the efficacy and safety of recombinant human interferon 2b spray (pseudomonas) in the treatment of acute upper respiratory tract infection in children. Zhongguo Shi Yong Er Ke Za Zhi. 2019;34:1010–6 (in Chinese). Shen KL, Shang YX, Zhang H. A multicenter, randomized, controlled clinical study on the efficacy and safety of recombinant human interferon 2b spray (pseudomonas) in the treatment of acute upper respiratory tract infection in children. Zhongguo Shi Yong Er Ke Za Zhi. 2019;34:1010–6 (in Chinese).
11.
go back to reference Gao H, Zhang LL, Qin C, Duan ZJ, Tu XM, Yu ZA, et al. Experimental study on the prevention and treatment of SARS-CoV infection in rhesus monkeys with recombinant human interferon 2b nasal spray. Chin J Exp Clin Virol. 2005;19:207–11 (in Chinese). Gao H, Zhang LL, Qin C, Duan ZJ, Tu XM, Yu ZA, et al. Experimental study on the prevention and treatment of SARS-CoV infection in rhesus monkeys with recombinant human interferon 2b nasal spray. Chin J Exp Clin Virol. 2005;19:207–11 (in Chinese).
12.
go back to reference Wang HQ, Ma LL, Jiang JD, Pang R, Chen YJ, Li YH, et al. Study on the pharmacodynamics of recombinant human interferon alpha 2b against respiratory viruses. Yao Xue Xue Bao. 2014;49:1547–53 (in Chinese). Wang HQ, Ma LL, Jiang JD, Pang R, Chen YJ, Li YH, et al. Study on the pharmacodynamics of recombinant human interferon alpha 2b against respiratory viruses. Yao Xue Xue Bao. 2014;49:1547–53 (in Chinese).
13.
go back to reference Yu DX, Chen Q, Zhang LL, Liu Y, Yu ZA, Li ZF, et al. Experimental study of recombinant human interferon 2b aerosol in the prevention of respiratory virus infections such as SARS in human populations. Chin J Exp Clin Virol. 2005;19:216–9 (in Chinese). Yu DX, Chen Q, Zhang LL, Liu Y, Yu ZA, Li ZF, et al. Experimental study of recombinant human interferon 2b aerosol in the prevention of respiratory virus infections such as SARS in human populations. Chin J Exp Clin Virol. 2005;19:216–9 (in Chinese).
Metadata
Title
Diagnosis and treatment of 2019 novel coronavirus infection in children: a pressing issue
Authors
Kun-Ling Shen
Yong-Hong Yang
Publication date
01-06-2020
Publisher
Springer Singapore
Published in
World Journal of Pediatrics / Issue 3/2020
Print ISSN: 1708-8569
Electronic ISSN: 1867-0687
DOI
https://doi.org/10.1007/s12519-020-00344-6

Other articles of this Issue 3/2020

World Journal of Pediatrics 3/2020 Go to the issue